US-China Symposium on the State-of-the-Science of Cancer Research and Future Directions for Global Collaboration
Dr. Zhu Chen, China's Minister of Health, Addresses at the Opening Reception of US-China Symposium
Minister Zhu Chen converses with Dr. Anna Barker, ASU Director of Transformative Healthcare Networks and former NCI Deputy Director
Government-Academia-Industry-Non-Profit Collaboration in Cancer Research
Left to Right: Minister Zhu Chen, Dr. Anna Barker, Dr. Sree Kaimal, Dr. Steven Averbuch, Mr. Franklin Salisbury, Jr., Dr. Scott Patterson
|AFCR President Dr. Sujuan Ba and CAMS President Dr. Xuetao Cao||Minister Chen talks with Dr. Ba, Dr. Albert Yu and Mr. Gary Wong from Hong Kong academia and industry|
The National Foundation for Cancer Research (NFCR) and the Chinese Academy of Medical Sciences (CAMS) joined hands to successfully host a high-level symposium in Beijing from November 4-6, 2012.
The US-China Symposium on the State-of-the-Science of Cancer Research and Future Directions for Global Collaboration brought together leading cancer researchers from the United States and China to launch an actionable roadmap for international research collaboration that will accelerate innovative cancer research and discovery.
This Symposium was a transformative opportunity for shaping the future direction of cancer research in the U.S. and China. "Through stronger partnerships with our scientific and corporate colleagues in the United States, we hope to advance our efforts to build a more effective research platform for government and industry toward shared progress in research to cure cancer," said Dr. Xuetao Cao, President of the Chinese Academy of Medical Sciences and co-host of the Symposium.
The topics addressed dring the 2012 Symposium will help build bridges between and among cancer researchers regardless of field or national boundaries. "Developing action plans that foster global collaboration in cancer research will both accelerate scientific discoveries and their development into new therapies," said Franklin Salisbury, Jr. President of the National Foundation for Cancer Research and co-host of the Symposium.
"We salute this type of synergistic collaboration across international borders, and are pleased to be a part of this Symposium," said Dr. Sujuan Ba, President of the Asian Fund for Cancer Research and sponsor of the Symposium. Other sponsors include:m Amgen, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Cancer Institute & Hospital of CAMS, and Eli Lilly & Company.
Symposium Speakers and Format
The two-day Symposium brought together prominent cancer researchers from government, academia, and industry to create a platform for global collaboration in cancer research that will foster scientific innovation and discovery.
A Plenary Session featured Chinese Minister of Health Zhu Chen, M.D., Ph.D., and Anna Barker, Ph.D., Director, Arizona State University Transformative Healthcare Networks and former Deputy Director of the U.S. National Cancer Institute (NCI). In his speech, Minister Chen stated that tissue banking, clinical trials, traditional Chinese medicine (TCM) and natural products, among other areas, will be the key collaboration fields between US and China in the near future.
Academicians and leading scientists participating in the Symposium include:
- Steven Averbuch, M.D., Bristol Myers Squibb
- Anahita Bhathena, Ph.D., Abbott Laboratories
- Xuetao Cao, M.D, Ph.D., Chinese Academy of Medical Sciences
- Webster Cavenee, Ph.D., Ludwig Institute for Cancer Research
- Shujun Cheng, M.D., Cancer Institute & Hospital Chinese Academy of Medical Sciences
- Yung-Chi Cheng, Ph.D., Yale University Medical School
- Carlo Croce, M.D., Ohio State University Medical Center
- Jianren Gu, M.D., Ph.D., Shanghai Cancer Institute, Shanghai Jiao Tong University
- Xi-Shan Hao, M.D., Chinese Anti-Cancer Association, Tianjin Medical University Cancer Institute
- Waun Ki Hong, M.D., MD Anderson Cancer Center
- Susan Horwitz, Ph.D., Albert Einstein College of Medicine
- Scott Patterson, Ph.D., Amgen
- George Sledge, Jr., Ph.D., Indiana University School of Medicine
- Yan Sun, M.D., Cancer Institute & Hospital Chinese Academy of Medical Sciences
- Zhaoyou Tang, M.D., Liver Cancer Institute, Fudan University
- Peter Vogt, Ph.D., The Scripps Research Institute
- Qimin Zhan, M.D., Chinese Academy of Medical Sciences
Symposium Topics included:
- Pathway for New Therapy Development in China and Vision for International Collaboration
- Global Clinical Development Networks: 21st Century Approach for Clinical Trials
- Biobanking and Translational Cancer Research
- New Paradigm for Treating Cancer: Traditional Chinese Medicine and Natural Products
- Cancer Genome and Personalized Medicines: Developing Genetic-Based Cancer Therapies
- Biomarkers and Molecular Medicine - Academic, Biotech, and Large Pharma Perspectives
- A Collaborative Approach to Defeat GBM - A Model for International Collaboration
November 4-6, 2012
Radegast Lake View Hotel
No.19 Panjiayuan South Road,Chaoyang District
Beijing 100021, China, 100021
Chinese Academy of Medical Sciences (CAMS)
National Foundation for Cancer Research (NFCR)
For any inquiries about the Symposium, please contact Monica Zhang at email@example.com.
About the National Foundation for Cancer Research
The National Foundation for Cancer Research (NFCR) is a leading charity dedicated to funding innovative cancer research worldwide. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery, and since 1973 NFCR has spent over $300 million funding the "high risk/high reward" research responsible for many breakthroughs in cancer research. NFCR is committed to solving cancer's molecular mysteries, and translating these discoveries into new approaches to preventing, diagnosing and treating cancer. NFCR is about Research for a Cure-cures for all types of cancer. For more information, please visit www.NFCR.org.
About the Chinese Academy of Medical Sciences
The Chinese Academy of Medical Sciences (CAMS) is the most important medical institution in China and is directly under the leadership of the Ministry of Health. The CAMS was created in 1956 by the Chinese government and was merged with Peking Union Medical College (PUMC) in Beijing. The mission of CAMS is to encourage high-quality research in biomedical science with the aim of improving people's health and reducing the death rate, to offer the best clinical diagnoses and treatments for severe and rare diseases, to promote the transition of research to clinical applications, and to train first-rate medical professionals for research, clinical applications, and education. For more information, please visit, www.CAMS.ac.cn.
About the Asian Fund for Cancer Research
The Asian Fund for Cancer Research (AFCR) is committed to curing cancers that have significant impacts on Asian populations. Headquartered in Hong Kong, AFCR is dedicated to bridging the scientific and educational gaps in cancer research and cancer prevention between Asian countries and the rest of the world, through promoting, coordinating and funding international collaboration in cancer research and public education. AFCR is devoted to reducing the incidence and increasing the survival rate of cancers in Asia. For more information, please visit www.AFCR.org.hk.